doi: 10.1016/j.clnesp.2020.04.010
Robert, what do you think
Our programs may include GLP-1 and GIP-based medications when clinically appropriate, such as tirzepatide and semaglutide helping support appetite control, metabolism, and long-term weight management
However, it is important to note that there are certain groups of people who SHOULD NOT attempt intermittent fasting without close medical supervision: Individuals who are on medication or suffer from chronic diseases such as diabetes mellitus, hypertension, cardiovascular disease (previous heart attack, stroke, peripheral vascular diseases), cancers, etc
Detoxification of Acyl Groups Metabolism generates intermediate acyl-CoA molecules, which, if left unchecked, can disrupt cellular functions
it is the foundational requirement for the next chapter of GLP-1 innovation